Differential Expression of miR-136 in Gestational Diabetes Mellitus Mediates the High-Glucose-Induced Trophoblast Cell Injury through Targeting E2F1

Figure 1

Expression of miR-136 in GDM patients and its diagnostic value evaluation. (a) GDM patients had higher serum miR-136 expression than the healthy controls (). (b) Expression of miR-136 in placental tissues was elevated in GDM patients compared with the healthy pregnancy women (). (c) Serum miR-136 was positively correlated with tissue miR-136 in GDM patients (, ). (d) Serum miR-136 levels were positively correlated with patients’ FBG (, ). (e) A positive correlation was observed between tissue miR-136 and FBG in GDM patients (, ).

(a)

(b)

(c)

(d)

(e)